For research use only. Not for therapeutic Use.
SB-408124(Cat No.:I002988)is a selective antagonist of the histamine H4 receptor, a receptor involved in immune and inflammatory responses. By blocking H4 receptors, SB-408124 helps modulate the activity of immune cells, particularly mast cells and eosinophils, which are key players in allergic and inflammatory conditions. It has been studied in preclinical models for its potential to treat conditions such as asthma, allergic rhinitis, and other inflammatory diseases. SB-408124’s selective inhibition of the H4 receptor makes it a valuable tool for exploring novel therapeutic strategies in immune-related disorders.
Catalog Number | I002988 |
CAS Number | 288150-92-5 |
Synonyms | 1-(6,8-difluoro-2-methylquinolin-4-yl)-3-[4-(dimethylamino)phenyl]urea |
Molecular Formula | C19H18F2N4O |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | DMSO 36 mg/mL; Water <1 mg/mL |
Storage | 3 years -20C powder |
IC50 | 57 nM(Ki) |
IUPAC Name | 1-(6,8-difluoro-2-methylquinolin-4-yl)-3-[4-(dimethylamino)phenyl]urea |
InChI | InChI=1S/C19H18F2N4O/c1-11-8-17(15-9-12(20)10-16(21)18(15)22-11)24-19(26)23-13-4-6-14(7-5-13)25(2)3/h4-10H,1-3H3,(H2,22,23,24,26) |
InChIKey | JTARFZSNUAGHRB-UHFFFAOYSA-N |
SMILES | CC1=CC(=C2C=C(C=C(C2=N1)F)F)NC(=O)NC3=CC=C(C=C3)N(C)C |
Reference | <p style=/line-height:25px/> <br>[2]. Morairty SR, et al. Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone.PLoS One. 2012;7(7):e39131. Epub 2012 Jul 2. <br>[3]. Melis MR, et al. Neuroendocrine regulatory peptide-1 and neuroendocrine regulatory peptide-2 influence differentially feeding and penile erection in male rats: sites of action in the brain.Regul Pept. 2012 Aug 20;177(1-3):46-52. Epub 2012 May 2. <br>[4]. Assisi L, et al. Expression and role of receptor 1 for orexins in seminiferous tubules of rat testis.Cell Tissue Res. 2012 Jun;348(3):601-7. Epub 2012 Mar 28. <br>[5]. Kis GK, et al. The osmotically and histamine-induced enhancement of the plasma vasopressin level is diminished by intracerebroventricularly administered orexin in rats.Pflugers Arch. 2012 Apr;463(4):531-6. Epub 2012 Feb 16. </p> |